NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundIn Parkinson's disease, decreased neuromelanin and increased Fe concentrations derive from the loss of neuromelanin-containing neurons in the substantia nigra, which is spared in Alzheimer's disease. We aimed to measure neuromelanin and Fe concentrations in post mortem midbrain subregions of patients with Parkinson's and Alzheimer's disease, and to investigate their effect on MRI signals.MethodsWe imaged neuromelanin in brain slices of Parkinson's (N = 4) and Alzheimer's disease (N = 7) subjects using neuromelanin-sensitive MRI sequences, compared the results with neuromelanin and Fe concentrations in the same sections, and calculated imaging maps for each subject.ResultsBoth neuromelanin and Fe concentrations provided unique contributions to neuromelanin-MRI. Compared to Alzheimer's disease, subjects with Parkinson's disease exhibited increased neuromelanin-MRI values in the superior colliculus and periaqueductal gray matter, and higher Fe concentration in the substantia nigra.ConclusionResults support the use of neuromelanin-MRI to study neuromelanin and Fe in substantia nigra and neighboring regions for investigating patients with Parkinson's disease and other movement disorders.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.